SPC148

Ledípasvír

  • Status:
    Veitt
  • Application date:
    18.2.2016
  • Application published:
    15.3.2016
  • Grant published:
    15.11.2019
  • Max expiry date:
    17.5.2030
  • Medicine name:
    Harvoni
  • Medicine for children:
    Yes

Timeline

Today
18.2.2016Application
15.3.2016Publication
15.11.2019Registration
17.5.2030Expires

Marketing license

  • IS authorization number:
    EU/1/14/958/001-002
  • Date:
    9.12.2014
  • Foreign authorization number:
    EU/1/14/958
  • Date:
    17.11.2014

Owner

  • Name:
    Gilead Pharmasset LLC
  • Address:
    333 Lakeside Drive, Foster City US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents